Q301--Long -Term Specialized Reference Laboratory for Measurable Residual Disease (MRD) detection in hematologic malignancies - Base Plus 4 9/1/26-8/31/31
VETERANS AFFAIRS, DEPARTMENT OF.VETERANS AFFAIRS, DEPARTMENT OF.260-NETWORK CONTRACT OFFICE 20 (36C260)
At a glance
This is a government contract opportunity posted by VETERANS AFFAIRS, DEPARTMENT OF in the medical laboratories category. The deadline is July 10, 2026, 8 days from now.
Classification and identifiers
- Industry (NAICS)
- Medical Laboratories (621511)
- Product or service (PSC)
- Reference Laboratory Testing (Q301)
- Solicitation number
- 36C26026Q0807
About this opportunity
STATEMENT OF WORK (SOW) for Reference Laboratory Services for specialized testing for Measurable Residual Disease (MRD) detection in hematologic malignancies BACKGROUND The VA Portland Healthcare System (VHAPORHCS) Pathology & Laboratory Medicine Service Department requires continued access to specialized testing for Measurable Residual Disease (MRD) detection in hematologic malignancies. MRD is a powerful diagnostic and prognostic tool that quantifies the presence of residual cancer cells during and after treatment in patients with multiple myeloma, B-cell acute lymphoblastic leukemia (B-ALL), and chronic lymphocytic leukemia (CLL). The contractor shall provide MRD testing of an FDA-cleared, next generation sequencing (NGS)-based assay for blood and bone marrow samples from patients diagn...